Multimodal sequencing of neoadjuvant nivolumab treatment in hepatocellular carcinoma reveals cellular and molecular immune landscape for drug response
Abstract A striking characteristic of liver cancer is its extensive heterogeneity, particularly with regard to its varied response to immunotherapy. In this study, we employed multimodal sequencing approaches to explore the various aspects of neoadjuvant nivolumab treatment in liver cancer patients....
Saved in:
| Main Authors: | Fanhong Zeng, Qingyang Zhang, Yu-Man Tsui, Huanhuan Ma, Lu Tian, Abdullah Husain, Jingyi Lu, Joyce Man-Fong Lee, Vanilla Xin Zhang, Po-Man Li, Gary Cheuk-Hang Cheung, Tan-To Cheung, Daniel Wai-Hung Ho, Irene Oi-Lin Ng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Molecular Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12943-025-02314-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer
by: Drew M Pardoll, et al.
Published: (2020-10-01) -
Phase I study on neoadjuvant combination immunotherapy with mogamulizumab and nivolumab for solid tumors
by: Takashi Kojima, et al.
Published: (2025-04-01) -
Resilience as a Positive Youth Development Construct: A Conceptual Review
by: Tak Yan Lee, et al.
Published: (2012-01-01) -
An Observational Study of a Severe Squall Line Crossing Hong Kong on 15 March 2025 Based on Radar-Retrieved Three-Dimensional Winds and Flight Data
by: Pak-wai Chan, et al.
Published: (2025-08-01) -
Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE study
by: Tanja D de Gruijl, et al.
Published: (2024-09-01)